This chapter aligns with Goal 3: Good Health and Wellbeing and Goal 15: Life on Land by considering best practices for using anesthesia on laboratory animals to promote laboratory animal welfare.

A Pragmatic Guide to Low Intensity Psychological Therapy Care in High Volume, 2023, Pages 111-135

This content aligns with Goal 3: Good Health as well as Goal 17: Partnership for the goals by discussing how Low Intensity Psychological Therapy can be incorporated with regards to gender and sexual diversity
This Article supports SDG 3 by examining whether birth-dose vaccination, compared with vaccination at 6-8 weeks or no vaccination, is effective in preventing horizonal transmission of HBV in children aged 0-5 years of uninfected mothers.
Elsevier,

Annals of Hepatology, Volume 28, 1 May 2023

This article aligns with the SDG goal 3 of Good health and wellbeing and SDG 10 Reduced inequalities by showing that hepatitis C mortality trends in Mexico have started to decrease, but that much remains to be done in terms of prevention, diagnosis and timely access to treatment in this country.
Elsevier,

Clinical Neuroepidemiology of Acute and Chronic Disorders, First Edition, 2023, pp 199-211

This chapter advances the UN SDG goals 3 and 17 by reviewing the basics understandings of delirium and dementia.

Promoting Desired Lifestyles Among Adults with Severe Autism and Intellectual Disabilities Person Centered Applications of Behavior Analysis, 2023, Pages 87-111

This content aligns with Goal 3: Good Health as well as Goal 17: Partnership for the goals by discussing how modular youth psychotherapies can help treat youth anxiety.
This Article supports Sustainable Development Goal 3 by showing a positive association between hearing loss without hearing aid use and dementia in adults aged 40-69 years in the UK. The authors analysed all-cause dementia, as well as specific types including Alzheimer's disease. Hearing loss was associated with increased risk of dementia, and using hearing aids was associated with a similar risk of dementia to no hearing loss, suggesting that hearing aid use in people with hearing loss could reduce dementia risk.
Elsevier,

Nitric Oxide - Biology and Chemistry, Volume 134-135, 1 May 2023

Nitric Oxide can act as both protecting and aggravating factor in Alzheimer's Disease. Nitric oxide can be considered as a neurotoxic factor in Alzheimer's Disease. Nitric Oxide induces neuro plasticity, neuroprotection, neurogenesis, long-term potentiation, and myelination. Drugs based on Nitric Oxide have shown promising results in Alzheimer's Disease. Nitric Oxide can via sundry ways ameliorate memory formation.
This study assessed the central auditory processing (CAP) function and its electroencephalogram (EEG) in patients with mild cognitive impairment (MCI) and the early stage of Alzheimer's disease (AD) so as to provide a basis for early recognition and intervention of AD.
An insightful paper on the effects that Nordic Walking can have on the cognitive function of patients with mild Alzheimer’s disease.

Pages